Equity awards to GE HealthCare (GEHC) executive Kevin O’Neill detailed

Rhea-AI Filing Summary

GE HealthCare Technologies reported that Kevin Michael O'Neill, CEO of PDx, received equity awards on March 2, 2026. He was granted 17,218 employee stock options at an exercise price of $0.00 per share and 6,549 shares of common stock as a stock award, all held directly.

The options will become exercisable in three installments of 33%, 33%, and 34% on September 2, 2027, September 2, 2028, and September 2, 2029. A separate restricted stock unit award will vest on the same 33%, 33%, 34% schedule. O'Neill also has 59 shares held indirectly through a share incentive plan trust.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider O'Neill Kevin Michael

Role CEO, PDx

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	17,218	$0.00	--
Grant/Award	Common Stock, par value $0.01 per share	6,549	$0.00	--
holding	Common Stock, par value $0.01 per share	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 17,218 shares (Direct); Common Stock, par value $0.01 per share — 32,744 shares (Direct); Common Stock, par value $0.01 per share — 59 shares (Indirect, By share incentive plan trust)

Footnotes (1)

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Kevin Michael

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, PDx

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	03/02/2026		A		6,549(1)(2)	A	$0	32,744	D
Common Stock, par value $0.01 per share								59	I	By share incentive plan trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		17,218		(3)	03/02/2036	Common Stock, par value $0.01 per share	17,218	$0(3)	17,218	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did GEHC executive Kevin Michael O'Neill report?

Kevin Michael O'Neill reported equity awards, not open-market trades. He received 17,218 employee stock options at an exercise price of $0.00 per share and 6,549 shares of common stock as a direct stock award, all dated March 2, 2026.

How many stock options did Kevin Michael O'Neill receive from GE HealthCare (GEHC)?

Kevin Michael O'Neill received 17,218 employee stock options. These options are rights to buy GE HealthCare common stock and were granted at an exercise price of $0.00 per share, with future exercisability based on a multi-year vesting schedule.

What common stock award did Kevin Michael O'Neill receive in this GEHC Form 4?

He received 6,549 shares of GE HealthCare common stock as a stock award. This was reported as an acquisition transaction at a price of $0.00 per share, increasing his directly held common stock balance to 32,744 shares after the grant.

What is the vesting schedule for Kevin Michael O'Neill’s GEHC restricted stock units?

The restricted stock units vest over three years. According to the disclosure, 33% vest on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029, each settling into GE HealthCare common shares.

When do Kevin Michael O'Neill’s GEHC employee stock options become exercisable?

The employee stock options become exercisable in three tranches. Specifically, 33% become exercisable on September 2, 2027, another 33% on September 2, 2028, and the final 34% on September 2, 2029, following the stated schedule.

Does Kevin Michael O'Neill hold any GEHC shares indirectly through a plan or trust?

Yes. The filing notes that 59 GE HealthCare common shares are held indirectly. These are held “by share incentive plan trust,” indicating an indirect ownership interest separate from his directly held and awarded shares.